We are live on ! Find out more
AGN

Allergan plc
AGN

Delisted

AGN was delisted on the 8th of May, 2020.

753 hedge funds and large institutions have $55.9B invested in Allergan plc in 2014 Q3 according to their latest regulatory filings, with 138 funds opening new positions, 374 increasing their positions, 189 reducing their positions, and 49 closing their positions.

New
Increased
Maintained
Reduced
Closed

182% more first-time investments, than exits

New positions opened: 138 | Existing positions closed: 49

98% more repeat investments, than reductions

Existing positions increased: 374 | Existing positions reduced: 189

96% more call options, than puts

Call options by funds: $1.97B | Put options by funds: $1B

41% more capital invested

Capital invested by funds: $39.7B → $55.9B (+$16.3B)

35% more funds holding in top 10

Funds holding in top 10: 84113 (+29)

12% more funds holding

Funds holding: 674753 (+79)

Holders
753
Holders Change
+79
Holders Change %
+11.72%
% of All Funds
21.84%
Holding in Top 10
113
Holding in Top 10 Change
+29
Holding in Top 10 Change %
+34.52%
% of All Funds
3.28%
New
138
Increased
374
Reduced
189
Closed
49
Calls
$1.97B
Puts
$1B
Net Calls
+$965M
Net Calls Change
+$483M
Name Holding Trade Value Shares
Change
Change in
Stake
Aviva
201
Aviva
United Kingdom
$26.2M +$8.37M +37,411 +52%
VRS
202
Virginia Retirement Systems
Virginia
$26.2M +$12.6M +56,204 +107%
SOMRS
203
State of Michigan Retirement System
Michigan
$26.1M +$8.26M +36,890 +52%
BTS
204
BB&T Securities
Virginia
$26.1M +$778K +3,477 +47%
CA
205
Commerzbank Aktiengesellschaft
Germany
$26M +$14.4M +64,346 +148%
GMI
206
Greystone Managed Investments
Saskatchewan, Canada
$25.3M -$14.3M -63,809 -38%
MCM
207
Maryland Capital Management
Maryland
$25M -$264K -1,180 -1%
Point72 Asset Management
208
Point72 Asset Management
Connecticut
$24.8M +$17.4M +77,900 +312%
TPSF
209
Texas Permanent School Fund
Texas
$24.8M +$6.28M +28,065 +38%
SCI
210
Seneca Capital Investments
New York
$24.8M -$16M -71,400 -41%
MF
211
Magnetar Financial
Illinois
$24.7M -$37.9M -169,160 -62%
Tudor Investment Corp
212
Tudor Investment Corp
Connecticut
$24.4M -$68.7K -307 -0.3%
AAM
213
Aberdeen Asset Management
United Kingdom
$24.3M +$5.04M +22,543 +29%
VOAM
214
Vertex One Asset Management
British Columbia, Canada
$24.2M +$22.5M +100,387 New
AIG
215
American International Group
New York
$24.1M +$7.19M +32,150 +48%
Marshall Wace
216
Marshall Wace
United Kingdom
$23.9M -$1.18M -5,278 -5%
SM
217
Scoggin Management
New York
$23.5M +$19.6M +87,500 +875%
Public Sector Pension Investment Board (PSP Investments)
218
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$23.5M +$6.24M +27,867 +40%
LOM
219
Loeb Offshore Management
New York
$22.9M +$21.3M +94,987 New
CPC
220
Cookson Peirce & Co
Pennsylvania
$22.8M -$51.5K -230 -0.2%
MSR
221
Main Street Research
Connecticut
$22.3M -$1.8M -8,065 -8%
TSU
222
TD Securities (USA)
New York
$22.3M -$11.4K -51 -0.1%
MSA
223
Mason Street Advisors
Wisconsin
$22.1M +$20.5M +91,641 New
CB
224
Commerce Bank
Missouri
$22M +$4.41M +19,696 +27%
AP
225
Alydar Partners
Massachusetts
$21.7M -$38M -170,000 -65%

AGN Hedge Fund Activity: Q3 2014 in Review

753 of the 3,448 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN) for Q3 2014, worth a combined $55.9B — up 41% from $39.7B a quarter earlier.

Buyers outnumbered sellers: 138 funds opened new AGN positions and 49 closed out — a net gain of 89 holders — while 374 added to existing stakes and 189 trimmed.

The largest buyer was ClearBridge Investments, opening a new position worth an estimated $1.74B. The largest seller was AllianceBernstein, cutting an estimated $200M.

  • 753 institutional investors held Allergan plc (AGN) as of Q3 2014, up from 674 in Q2 2014.
  • Funds reported $55.9B of Allergan plc stock for Q3 2014, up 41% quarter-over-quarter.
  • 138 funds opened new Allergan plc positions in Q3 2014 and 49 closed out, a net change of +89 holders.
  • The largest Allergan plc buyer in Q3 2014 was ClearBridge Investments, an estimated $1.74B added.
  • The largest Allergan plc seller in Q3 2014 was AllianceBernstein, an estimated $200M sold.

Based on aggregated 13F filings for Q3 2014.